vs
BXP, Inc.（BXP）与爱德华生命科学（EW）财务数据对比。点击上方公司名可切换其他公司
爱德华生命科学的季度营收约是BXP, Inc.的1.9倍（$1.6B vs $872.1M），爱德华生命科学净利率更高（23.1% vs 15.3%，领先7.8%），爱德华生命科学同比增速更快（16.7% vs 0.8%），过去两年爱德华生命科学的营收复合增速更高（9.7% vs 1.3%）
BXP是美国头部商业地产投资信托企业，核心业务为持有、运营及开发A级高端写字楼资产，项目覆盖纽约、波士顿、旧金山等美国核心都市圈，服务企业、科技、专业服务等领域的多元租户。
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
BXP vs EW — 直观对比
营收规模更大
EW
是对方的1.9倍
$872.1M
营收增速更快
EW
高出15.9%
0.8%
净利率更高
EW
高出7.8%
15.3%
两年增速更快
EW
近两年复合增速
1.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $872.1M | $1.6B |
| 净利润 | $133.0M | $380.7M |
| 毛利率 | — | 78.0% |
| 营业利润率 | — | 1.8% |
| 净利率 | 15.3% | 23.1% |
| 营收同比 | 0.8% | 16.7% |
| 净利润同比 | 53.0% | 6.8% |
| 每股收益（稀释后） | $1.69 | $0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BXPEW
| Q1 26 | $872.1M | $1.6B | ||
| Q4 25 | $877.1M | $1.6B | ||
| Q3 25 | $871.5M | $1.6B | ||
| Q2 25 | $868.5M | $1.5B | ||
| Q1 25 | $865.2M | $1.4B | ||
| Q4 24 | $858.6M | $1.4B | ||
| Q3 24 | $859.2M | $1.4B | ||
| Q2 24 | $850.5M | $1.4B |
净利润BXPEW
| Q1 26 | $133.0M | $380.7M | ||
| Q4 25 | $248.4M | $91.2M | ||
| Q3 25 | $-121.7M | $291.1M | ||
| Q2 25 | $89.0M | $333.2M | ||
| Q1 25 | $61.2M | $358.0M | ||
| Q4 24 | $-228.9M | $385.6M | ||
| Q3 24 | $83.6M | $3.1B | ||
| Q2 24 | $79.6M | $366.3M |
毛利率BXPEW
| Q1 26 | — | 78.0% | ||
| Q4 25 | 58.8% | 78.1% | ||
| Q3 25 | 59.3% | 77.8% | ||
| Q2 25 | 59.2% | 77.5% | ||
| Q1 25 | 59.2% | 78.7% | ||
| Q4 24 | 59.7% | 78.9% | ||
| Q3 24 | 59.5% | 80.6% | ||
| Q2 24 | 59.8% | 79.9% |
营业利润率BXPEW
| Q1 26 | — | 1.8% | ||
| Q4 25 | — | 9.6% | ||
| Q3 25 | — | 19.8% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 27.9% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 25.9% | ||
| Q2 24 | — | 26.8% |
净利率BXPEW
| Q1 26 | 15.3% | 23.1% | ||
| Q4 25 | 28.3% | 5.8% | ||
| Q3 25 | -14.0% | 18.7% | ||
| Q2 25 | 10.2% | 21.7% | ||
| Q1 25 | 7.1% | 25.3% | ||
| Q4 24 | -26.7% | 27.8% | ||
| Q3 24 | 9.7% | 226.7% | ||
| Q2 24 | 9.4% | 26.7% |
每股收益（稀释后）BXPEW
| Q1 26 | $1.69 | $0.66 | ||
| Q4 25 | $1.56 | $0.16 | ||
| Q3 25 | $-0.77 | $0.50 | ||
| Q2 25 | $0.56 | $0.56 | ||
| Q1 25 | $0.39 | $0.61 | ||
| Q4 24 | $-1.46 | $0.65 | ||
| Q3 24 | $0.53 | $5.13 | ||
| Q2 24 | $0.51 | $0.61 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $512.8M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.7B | — |
| 总资产 | $25.1B | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BXPEW
| Q1 26 | $512.8M | — | ||
| Q4 25 | $1.5B | $4.2B | ||
| Q3 25 | $861.1M | $3.8B | ||
| Q2 25 | $447.0M | $4.1B | ||
| Q1 25 | $398.1M | $3.9B | ||
| Q4 24 | $1.3B | $4.0B | ||
| Q3 24 | $1.4B | $4.4B | ||
| Q2 24 | $685.4M | $2.0B |
股东权益BXPEW
| Q1 26 | $7.7B | — | ||
| Q4 25 | $5.1B | $10.3B | ||
| Q3 25 | $5.0B | $10.2B | ||
| Q2 25 | $5.3B | $10.5B | ||
| Q1 25 | $5.3B | $10.1B | ||
| Q4 24 | $5.4B | $10.0B | ||
| Q3 24 | $5.8B | $9.5B | ||
| Q2 24 | $5.8B | $7.4B |
总资产BXPEW
| Q1 26 | $25.1B | — | ||
| Q4 25 | $26.2B | $13.7B | ||
| Q3 25 | $26.0B | $13.3B | ||
| Q2 25 | $25.6B | $13.5B | ||
| Q1 25 | $25.4B | $13.0B | ||
| Q4 24 | $26.1B | $13.1B | ||
| Q3 24 | $26.4B | $13.0B | ||
| Q2 24 | $25.5B | $10.1B |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BXP
| Lease | $818.2M | 94% |
| Parking and other | $30.8M | 4% |
| Development and management services | $9.2M | 1% |
EW
暂无分部数据
